JDOC · JPMorgan Healthcare Leaders ETF ETF
J.P. Morgan Exchange-Traded Fund Trust
$62.88
-1.16%
At close · Sep 4
Net assets $11,125,001
Holdings43
1 month
+1.84%
Year to date
+8.70%
52-week range
$50.34–$64.69
30-session avg volume
468
Market performance
Adjusted close · up to five years
Fund profile
- Structure
- Exchange-traded product
- SEC series
- S000080528
- Report date
- Apr 30, 2026
- Holdings coverage
- Tracked U.S. equities
Portfolio concentration
Top 10 holdings—
Calculated only when the SEC filing is stored with complete portfolio coverage.
Portfolio holdings
Latest linked SEC Form NPORT-P report.
| Holding | Ticker / CUSIP | Value | Weight |
|---|---|---|---|
| Eli Lilly & Co. | LLY | $757,961 | 6.81% |
| AbbVie, Inc. | ABBV | $732,012 | 6.58% |
| Johnson & Johnson | JNJ | $689,780 | 6.20% |
| UnitedHealth Group, Inc. | UNH | $648,710 | 5.83% |
| Merck & Co., Inc. | MRK | $468,273 | 4.21% |
| Bristol-Myers Squibb Co. | BMY | $389,412 | 3.50% |
| Thermo Fisher Scientific, Inc. | TMO | $354,430 | 3.19% |
| Intuitive Surgical, Inc. | ISRG | $329,022 | 2.96% |
| CVS Health Corp. | CVS | $301,343 | 2.71% |
| Regeneron Pharmaceuticals, Inc. | REGN | $243,229 | 2.19% |
| Boston Scientific Corp. | BSX | $227,329 | 2.04% |
| Vertex Pharmaceuticals, Inc. | VRTX | $217,964 | 1.96% |
| Danaher Corp. | DHR | $211,877 | 1.90% |
| Edwards Lifesciences Corp. | EW | $203,323 | 1.83% |
| McKesson Corp. | MCK | $198,094 | 1.78% |
| Stryker Corp. | SYK | $177,103 | 1.59% |
| Cardinal Health, Inc. | CAH | $153,532 | 1.38% |
| Centene Corp. | CNC | $147,057 | 1.32% |
| Biogen, Inc. | BIIB | $144,610 | 1.30% |
| Zoetis, Inc. | ZTS | $130,606 | 1.17% |
| United Therapeutics Corp. | UTHR | $129,125 | 1.16% |
| IQVIA Holdings, Inc. | IQV | $114,977 | 1.03% |
| Spyre Therapeutics, Inc. | SYRE | $98,795 | 0.89% |
| Apogee Therapeutics, Inc. | APGE | $95,489 | 0.86% |
| Ionis Pharmaceuticals, Inc. | IONS | $93,973 | 0.84% |
| CG oncology, Inc. | CGON | $87,029 | 0.78% |
| Align Technology, Inc. | ALGN | $76,916 | 0.69% |
| Immunome, Inc. | IMNM | $76,872 | 0.69% |
| Dyne Therapeutics, Inc. | DYN | $74,868 | 0.67% |
| Dexcom, Inc. | DXCM | $71,222 | 0.64% |
| Neurocrine Biosciences, Inc. | NBIX | $70,180 | 0.63% |
| Cigna Group (The) | CI | $67,124 | 0.60% |
| Alumis, Inc. | ALMS | $60,392 | 0.54% |
| Nuvalent, Inc. | 670703107 | $58,564 | 0.53% |
| Bio-Techne Corp. | TECH | $46,635 | 0.42% |
| Sionna Therapeutics, Inc. | SION | $46,479 | 0.42% |
| Disc Medicine, Inc. | IRON | $41,944 | 0.38% |
| Alnylam Pharmaceuticals, Inc. | ALNY | $34,663 | 0.31% |
| Viridian Therapeutics, Inc. | VRDN | $31,314 | 0.28% |
| Evommune, Inc. | EVMN | $29,988 | 0.27% |
| Xenon Pharmaceuticals, Inc. | XENE | $29,981 | 0.27% |
| HCA Healthcare, Inc. | HCA | $29,543 | 0.27% |
| Genmab A/S | GMAB | $13,870 | 0.12% |